Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
Abstract Aims Besides regulating calcium‐phosphate metabolism, fibroblast growth factor 23 (FGF‐23) has been associated with incident heart failure (HF) and left ventricular hypertrophy. However, data about FGF‐23 in HF and preserved ejection fraction (HFpEF) remain limited. The aim of this study wa...
Main Authors: | Clotilde Roy, Sibille Lejeune, Alisson Slimani, Christophe deMeester, Sylvie A. Ahn AS, Michel F. Rousseau, Amzulescu Mihaela, Audrey Ginion, Benjamin Ferracin, Agnès Pasquet, David Vancraeynest, Christophe Beauloye, Jean‐Louis Vanoverschelde, Sandrine Horman, Damien Gruson, Bernhard L. Gerber, Anne‐Catherine Pouleur |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12816 |
Similar Items
-
Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01) -
Cardiac effects of positive pressure ventilation in ARDS assessed by NT-proBNP, Troponin T and Troponin I
by: Yasser Sadek Nassar, et al.
Published: (2013-01-01) -
Inverted Takotsubo Syndrome With HELLP Syndrome: A Case Report
by: Paul Gabarre, et al.
Published: (2022-03-01) -
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer?
by: Renato de Falco, et al.
Published: (2021-06-01) -
Cardiovascular abnormalities in dogs with acute pancreatitis
by: Harry Cridge, et al.
Published: (2023-01-01)